Cargando…
Long‐term remission and survival in dogs with high‐grade, B cell lymphoma treated with chemotherapy with or without sequential low‐dose rate half‐body irradiation
BACKGROUND: Standard of care for dogs with high‐grade lymphoma, multiagent chemotherapy, achieves good initial responses but long‐term remissions are infrequent; previous studies using half‐body irradiation suggest improved long‐term outcomes. HYPOTHESIS: The addition of low‐dose rate half‐body irra...
Autores principales: | Best, Matthew P., Straw, Rod C., Gumpel, Elias, Fry, Darren R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658474/ https://www.ncbi.nlm.nih.gov/pubmed/37700548 http://dx.doi.org/10.1111/jvim.16840 |
Ejemplares similares
-
Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
por: Siewert, Jacob M., et al.
Publicado: (2023) -
Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy
por: Fournier, Q., et al.
Publicado: (2017) -
Efficacy of an elemental diet in achieving clinical remission in dogs with chronic enteropathy
por: Manchester, Alison C., et al.
Publicado: (2023) -
Grading of oligodendroglioma in dogs based on magnetic resonance imaging
por: Amphimaque, Bénédicte, et al.
Publicado: (2022) -
Genetic and environmental risk for lymphoma in boxer dogs
por: Craun, Kaitlyn, et al.
Publicado: (2020)